Aktie A3EV5Z J. B. CHEMICALS & PHARMACEUTICALS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen J. B. Chemicals & Pharmaceuticals Limited NSE India S.E.

Aktien

A3EV5Z

INE572A01036

JBCHEPHARM

Markt geschlossen - NSE India S.E.
Andere Börsenplätze
 13:42:30 30.04.2024 		% 5 Tage % 1. Jan.
1.905 INR -0,07 % Intraday Chart für J. B. Chemicals & Pharmaceuticals Limited +6,56 % +17,27 %
08.04. J. B. Chemicals & Pharmaceuticals Limited ernennt Akshay Tanna zum nicht-exekutiven, nicht-unabhängigen Direktor CI
09.03. J. B. Chemicals & Pharmaceuticals Limited gibt das Ableben von Ranjit Shahani, Chairman und Non-Executive, Independent Director, bekannt CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
J. B. Chemicals & Pharmaceuticals Limited Receives Order from Joint Commissioner State Tax, Lucknow II, Lucknow
J. B. Chemicals & Pharmaceuticals Limited Appoints Akshay Tanna as A Non-Executive, Non-Independent Director
J. B. Chemicals & Pharmaceuticals Limited Receives Order from Assessment Unit, Income Tax Department
J. B. Chemicals & Pharmaceuticals Limited Announces Demise of Ranjit Shahani, Chairman and Non-Executive, Independent Director
KKR Reportedly Considers Selling Controlling Stake in JB Pharma
JB Chemicals' Consolidated Profit Climbs in Fiscal Q3; Shares Jump 4%
J.B. Pharma Seeks Acquisitions
J. B. Chemicals & Pharmaceuticals Appoints CFO
JB Chemicals Names CFO
Indian drugmaker J B Chemicals posts Q3 profit rise on strong demand
J. B. Chemicals & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
J. B. Chemicals & Pharmaceuticals Limited Appoints Narayan Saraf as the Chief Financial Officer, with Effect from February 23, 2024
J. B. Chemicals & Pharmaceuticals Limited Declares Interim Dividend for Financial Year 2023-24
J B Chemicals & Pharmaceuticals : Earnings Call Transcript – Entry into Ophthalmology segment
J. B. Chemicals & Pharmaceuticals Limited Announces Execution of Trade Mark License Agreement with Novartis Innovative Therapies Ag and Promotion & Distribution Agreement with Novartis Healthcare Private Limited
JB Pharma Seeks Acquisitions
J.B. Chemicals Records Rise in Fiscal Q2 Consolidated Net Profit
J. B. Chemicals & Pharmaceuticals Limited Appoints Akshay Tanna as an Additional Director
J. B. Chemicals & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
J.B. Chemicals' CFO Resigns
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3EV5Z Aktie
  4. A3EV5Z Aktie
  5. Nachrichten J. B. Chemicals & Pharmaceuticals Limited
  6. Andere Sprachen